US 11,859,015 B2
Immunogenic WT-1 peptides and methods of use thereof
David A. Scheinberg, New York, NY (US); and Tao Dao, New York, NY (US)
Assigned to MEMORIAL SLOAN KETTERING CANCER CENTER, New York, NY (US)
Filed by MEMORIAL SLOAN KETTERING CANCER CENTER, New York, NY (US)
Filed on Aug. 31, 2020, as Appl. No. 17/007,415.
Application 17/007,415 is a division of application No. 15/920,335, filed on Mar. 13, 2018, granted, now 10,815,273.
Application 15/920,335 is a continuation in part of application No. 14/760,997, granted, now 9,919,037, issued on Mar. 20, 2018, previously published as PCT/US2014/011711, filed on Jan. 15, 2014.
Claims priority of provisional application 61/752,799, filed on Jan. 15, 2013.
Prior Publication US 2020/0392183 A1, Dec. 17, 2020
Int. Cl. C07K 7/06 (2006.01); C07K 7/08 (2006.01); A61K 38/10 (2006.01); A61P 35/00 (2006.01); A61K 38/08 (2019.01); C07K 14/47 (2006.01); A61K 45/06 (2006.01)
CPC C07K 7/06 (2013.01) [A61K 38/08 (2013.01); A61K 38/10 (2013.01); A61K 45/06 (2013.01); A61P 35/00 (2018.01); C07K 7/08 (2013.01); C07K 14/4748 (2013.01)] 20 Claims
 
1. An isolated peptide comprising the amino acid sequence NYMNLGATL (SEQ ID NO:7) other than the isolated peptide consisting of the amino acid sequence NYMNLGATL (SEQ ID NO:7).